Cargando…

Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation

INTRODUCTION: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN de-differentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. METHODS: Chrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovinazzo, Francesco, Schimmack, Simon, Svejda, Bernhard, Alaimo, Daniele, Pfragner, Roswitha, Modlin, Irvin, Kidd, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834250/
https://www.ncbi.nlm.nih.gov/pubmed/24260544
http://dx.doi.org/10.1371/journal.pone.0081111
_version_ 1782291950789984256
author Giovinazzo, Francesco
Schimmack, Simon
Svejda, Bernhard
Alaimo, Daniele
Pfragner, Roswitha
Modlin, Irvin
Kidd, Mark
author_facet Giovinazzo, Francesco
Schimmack, Simon
Svejda, Bernhard
Alaimo, Daniele
Pfragner, Roswitha
Modlin, Irvin
Kidd, Mark
author_sort Giovinazzo, Francesco
collection PubMed
description INTRODUCTION: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN de-differentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. METHODS: Chromogranin A mRNA (PCR) and protein (ELISA/western blot) were studied in 10 normal human mucosa, 5 enterochromaffin cell preparations, 26 small intestinal NEN primaries and 9 liver metastases. Cell viability (WST-1 assay), proliferation (bromodeoxyuridine ELISA) and expression of AKT/AKT-P (CASE ELISA/western blot) in response to chromogranin A silencing, inhibition of prohormone convertase and mTOR inhibition (RAD001/AKT antisense) as well as different chromogranin A fragments were examined in 4 SI-NEN cell lines. RESULTS: Chromogranin A mRNA and protein levels were increased (37-340 fold, p<0.0001) in small intestinal NENs compared to normal enterochromaffin cells. Western blot identified chromogranin A-associated processing bands including vasostatin in small intestinal NENs as well as up-regulated expression of prohormone convertase in metastases. Proliferation in small intestinal NEN cell lines was decreased by silencing chromogranin A as well as by inhibition of prohormone convertase (p<0.05). This inhibition also decreased secretion of chromogranin A (p<0.05) and 5-HT (p<0.05) as well as expression of vasostatin. Metastatic small intestinal NEN cell lines were stimulated (50-80%, p<0.05) and AKT phosphorylated (Ser473: p<0.05) by vasostatin I, which was completely reversed by RAD001 (p<0.01) and AKT antisense (p<0.05) while chromostatin inhibited proliferation (~50%, p<0.05). CONCLUSION: Chromogranin A was differentially regulated in primary and metastatic small intestinal NENs and cell lines. Chromogranin A fragments regulated metastatic small intestinal NEN proliferation via the AKT pathway indicating that CgA plays a far more complex role in the biology of these tumors than previously considered.
format Online
Article
Text
id pubmed-3834250
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38342502013-11-20 Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation Giovinazzo, Francesco Schimmack, Simon Svejda, Bernhard Alaimo, Daniele Pfragner, Roswitha Modlin, Irvin Kidd, Mark PLoS One Research Article INTRODUCTION: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN de-differentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. METHODS: Chromogranin A mRNA (PCR) and protein (ELISA/western blot) were studied in 10 normal human mucosa, 5 enterochromaffin cell preparations, 26 small intestinal NEN primaries and 9 liver metastases. Cell viability (WST-1 assay), proliferation (bromodeoxyuridine ELISA) and expression of AKT/AKT-P (CASE ELISA/western blot) in response to chromogranin A silencing, inhibition of prohormone convertase and mTOR inhibition (RAD001/AKT antisense) as well as different chromogranin A fragments were examined in 4 SI-NEN cell lines. RESULTS: Chromogranin A mRNA and protein levels were increased (37-340 fold, p<0.0001) in small intestinal NENs compared to normal enterochromaffin cells. Western blot identified chromogranin A-associated processing bands including vasostatin in small intestinal NENs as well as up-regulated expression of prohormone convertase in metastases. Proliferation in small intestinal NEN cell lines was decreased by silencing chromogranin A as well as by inhibition of prohormone convertase (p<0.05). This inhibition also decreased secretion of chromogranin A (p<0.05) and 5-HT (p<0.05) as well as expression of vasostatin. Metastatic small intestinal NEN cell lines were stimulated (50-80%, p<0.05) and AKT phosphorylated (Ser473: p<0.05) by vasostatin I, which was completely reversed by RAD001 (p<0.01) and AKT antisense (p<0.05) while chromostatin inhibited proliferation (~50%, p<0.05). CONCLUSION: Chromogranin A was differentially regulated in primary and metastatic small intestinal NENs and cell lines. Chromogranin A fragments regulated metastatic small intestinal NEN proliferation via the AKT pathway indicating that CgA plays a far more complex role in the biology of these tumors than previously considered. Public Library of Science 2013-11-19 /pmc/articles/PMC3834250/ /pubmed/24260544 http://dx.doi.org/10.1371/journal.pone.0081111 Text en © 2013 Giovinazzo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Giovinazzo, Francesco
Schimmack, Simon
Svejda, Bernhard
Alaimo, Daniele
Pfragner, Roswitha
Modlin, Irvin
Kidd, Mark
Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title_full Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title_fullStr Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title_full_unstemmed Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title_short Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
title_sort chromogranin a and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834250/
https://www.ncbi.nlm.nih.gov/pubmed/24260544
http://dx.doi.org/10.1371/journal.pone.0081111
work_keys_str_mv AT giovinazzofrancesco chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT schimmacksimon chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT svejdabernhard chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT alaimodaniele chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT pfragnerroswitha chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT modlinirvin chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation
AT kiddmark chromograninaanditsfragmentsasregulatorsofsmallintestinalneuroendocrineneoplasmproliferation